COMMUNIQUÉS West-GlobeNewswire

RespireRx Pharmaceuticals Inc. Announces Commencement of Rule 506(c) Private Placement
18/11/2025
Glen Rock, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases [...]
MATTER Celebrates Companies Building Stronger Communities Through Volunteerism
18/11/2025
Companies That Matter Event Highlights Major National Impact MINNEAPOLIS, MN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- MATTER hosted its second annual Companies That Matter celebration on November 17, 2025, honoring corporate [...]
Sarah Scott Named to Business Insurance’s “Women to Watch” List for 2025
18/11/2025
Scott recognized for improving patient care and advancing innovation in workers’ compensation at CorVel FORT WORTH, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation is proud to announce that Sarah Scott, [...]
Apollomics Announces Changes to its Board of Directors and Composition of Committees
18/11/2025
FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage clinical biopharmaceutical company, today announced the following [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer
18/11/2025
At interim analysis, giredestrant demonstrated a statistically significant and clinically meaningful benefit versus standard-of-care endocrine monotherapy These unprecedented results support its potential as a new [...]
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
18/11/2025
Strategy will combine internal innovation, licensing, and strategic acquisitions to drive sustainable value creation for shareholders Strategic initiative follows positive topline results from pivotal Phase 3 HERIZON- [...]
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
18/11/2025
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, [...]
HelixAI launches a new agentic operating system to bring the power of autonomous AI to life sciences
18/11/2025
PRESS RELEASE New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research and scientists to accelerate innovation Partnerships with NVIDIA, AWS and Sapio [...]
Uma inovação natural na proteção de cereais e culturas agrícolas
18/11/2025
Syngenta e Amoéba SA vão desenvolver e comercializar soluções de biocontrolo na UE e no Reino Unido Basileia, Suíça Chassieu, França, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Uma inovação natural na proteção de cereais e [...]
A natural breakthrough in protecting cereals and field crops
18/11/2025
Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK Chassieu, France Basel, Switzerland , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Amoebas. These single-celled microorganisms are now at the [...]
Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit
18/11/2025
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled [...]
Portsmouth Square, Inc. Reports Q1 FY2026 Results; Hotel KPIs Up, Continued Stabilization in San Francisco, and ~$10.1 Million in Cash & Restricted Cash
17/11/2025
Los Angeles, CA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (“Portsmouth” or the “Company”) reported results for the three months ended September 30, 2025. Management continues to conclude that the prior [...]
Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
17/11/2025
Artisan and Tulex Report Positive Phase 2a Results for Autism Drug ART-501 SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Artisan Therapeutics, Inc. (“Artisan”) and Tulex Pharmaceuticals (“Tulex”) today announced [...]
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
18/11/2025
NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 44,000,000 shares of its common stock at an offering price of [...]
New therapeutic approach to facilitate healing of bed sores
17/11/2025
Researchers from UBC and Vancouver Coastal Health are developing natural plant compounds into a healing gel that could speed up recovery and prevent wounds from returning VANCOUVER, British Columbia, Nov. 17, 2025 ( [...]
OSE Immunotherapeutics annonce que le Comité indépendant d’experts scientifiques (IDMC) recommande la poursuite d’ARTEMIA, l’essai pivot de Phase 3 de Tedopi® dans le cancer du poumon non à petites cellules
17/11/2025
OSE Immunotherapeutics annonce que le Comité indépendant d’experts scientifiques (IDMC) recommande la poursuite d’ARTEMIA, l’essai pivot de Phase 3 de Tedopi® dans le cancer du poumon non à petites cellules NANTES, le [...]
OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
17/11/2025
OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer NANTES, France, [...]
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH) , a clinical-stage biotechnology company developing an innovative research platform based [...]
Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants
17/11/2025
Yomi® S and YomiPlan® AI Platform Now FDA-Cleared, Offering Unprecedented Precision, Efficiency, and Access for Dentists and Patients MIAMI, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Neocis ® , the pioneer behind the first and [...]

Pages